AMRA is the only European company in the Diagnostics segment to receive the highest designation, recognizing its work in MRI-based muscle and fat analysis.
Corporate
HealthCap Invests in AMRA Medical to Accelerate Global Growth in Quantitative MRI
Investment positions AMRA to meet growing global demand for precise, scalable advanced muscle and fat imaging in clinical research and healthcare.
Today, June 20th, marks World FSHD Day
LINKÖPING, Sweden, June 20, 2026 –Across our AMRA family worldwide, we’re showing our support for the FSHD community today with a simple…
New Year, New Solutions: AMRA Medical Continues Commitment to Innovation & Data-Driven Excellence
LINKÖPING, Sweden, January 29, 2026 – AMRA Medical, the global leader in MRI-based fat distribution and muscle composition analytics, is excited to…
Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’
The inaugural ranking by TIME, in partnership with Statista, features AMRA as one of the world’s leading health technology companies that are “driving innovation, enhancing accessibility, and contributing to a more effective and sustainable health care system”
Celebrating 15 Years of Pioneering Body Composition Breakthroughs
Last week we celebrated AMRA’s 15th birthday at our headquarters in Linköping, Sweden—the place where a bold idea grew into a platform…